The Neuro technology company “Neuralink”, by Elon Musk, reported that it has raised about 650 million dollars in its last financing round while its brain implant device enters clinical trials.
“This financing helps us bring our technology closer to more people, returning independence to those who have non -covered medical needs and expanding the limits of the possible with brain interfaces,” said Neuralink.
It has started clinical trials for the device, which has a chip that processes neuronal signals that can be transmitted to computers or telephones, in three countries.
According to the company, five patients with severe paralysis are using Neuralink to control digital and physical devices with their thoughts. The company received the “innovative” label from the Food and EU drug administration for its speech restoration device.
Last year he received the same label for his vision restoration device. The Health Regulator Innovative Program aims to provide patients and medical care providers timely access to medical devices by accelerating development, evaluation and review, according to their website.
Find: Toyota will privatize a key supplier in a 33,000 MDD agreement
Musk Neuralink raises 650 MDD in its last financing while clinical trials begin
Musk said last Wednesday that he left his role as special advisor to US President Donald Trump to focus on his companies, including Tesla, Spacex, XAI, Neuralink and the Social Network Platform X.
According to media reports, Morgan Stanley is looking for a debt package of 5 billion dollars for XAI, and the artificial intelligence company seeks an valuation of 113 billion dollars in a sale of shares worth $ 300 million.
Neuralink closed its financing round with the participation of key investors, including Ark Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, Qia, Sequoia Capital, Thrive Capital, Value Equity Partners and Vy Capital, the company said.
Semafor reported last month that the startup had raised $ 600 million in an agreement that valued it at $ 9 billion before the new cash.
With Reuters information
Follow business information in our specialized section
